STOCK TITAN

Ekso Bionics to Present at the H.C. Wainwright BioConnect 2021 Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Ekso Bionics (Nasdaq: EKSO) announced its participation in the H.C. Wainwright BioConnect 2021 Virtual Conference from January 11-14, 2021. Jack Peurach, CEO, and Jack Glenn, CFO, will present at this event. An on-demand company presentation will be available starting January 11 at 6:00 AM ET on the company's website. Ekso Bionics specializes in exoskeleton technology aimed at enhancing strength and mobility for medical and industrial applications, furthering its mission to amplify human potential.

Positive
  • None.
Negative
  • None.

RICHMOND, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Peurach, President & Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will present at the H.C. Wainwright BioConnect 2021 Virtual Conference held January 11 – 14, 2021.

A company presentation will be available to view on-demand as of 6:00 AM ET / 3:00 AM PT, Monday, January 11, 2021 throughout the entirety of the conference and available on the investor section of the Company’s website at: www.eksobionics.com.

About Ekso Bionics® 
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.

Investor Contact:
David Carey
212-867-1768
investors@eksobionics.com


FAQ

When is the H.C. Wainwright BioConnect 2021 Virtual Conference?

The H.C. Wainwright BioConnect 2021 Virtual Conference will be held from January 11 to 14, 2021.

Who will present for Ekso Bionics at the conference?

Jack Peurach, President & CEO, and Jack Glenn, CFO, will present for Ekso Bionics.

What time will Ekso Bionics' presentation be available?

Ekso Bionics' presentation will be available on-demand starting at 6:00 AM ET on January 11, 2021.

Where can I watch Ekso Bionics' presentation?

The presentation can be viewed on the investor section of Ekso Bionics' website.

What does Ekso Bionics specialize in?

Ekso Bionics specializes in exoskeleton technology for enhancing human strength, endurance, and mobility.

Ekso Bionics Holdings, Inc.

NASDAQ:EKSO

EKSO Rankings

EKSO Latest News

EKSO Stock Data

14.96M
20.03M
7.91%
25.25%
0.34%
Medical Instruments & Supplies
General Industrial Machinery & Equipment, Nec
Link
United States of America
SAN RAFAEL